مصطلحات الفهرس: male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test
Journal of Pharmacy Practice and Research
Click here for full text options
LibKey Link

مصطلحات الفهرس: male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test
Journal of Pharmacy Practice and Research
LibKey Link

مصطلحات الفهرس: drug blood level, drug dose escalation, drug safety, drug tolerability, human, maximum tolerated dose, phase 1 clinical trial, phase 2 clinical trial, priority journal, solid malignant neoplasm/dt [Drug Therapy], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/cm [Drug Comparison], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/pd [Pharmacology], cyclodextrin, docetaxel/dt [Drug Therapy], macrogol, nanoparticle, antineoplastic agent/cr [Drug Concentration], antineoplastic activity, article, advanced cancer, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39641Test
Annals of Oncology
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug blood level, drug dose escalation, drug safety, drug tolerability, human, maximum tolerated dose, phase 1 clinical trial, phase 2 clinical trial, priority journal, solid malignant neoplasm/dt [Drug Therapy], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/cm [Drug Comparison], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/pd [Pharmacology], cyclodextrin, docetaxel/dt [Drug Therapy], macrogol, nanoparticle, antineoplastic agent/cr [Drug Concentration], antineoplastic activity, article, advanced cancer, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39641Test
Annals of Oncology
LibKey Link

مصطلحات الفهرس: cisplatin/dt [Drug Therapy], adult, aged, alopecia/co [Complication], alopecia/si [Side Effect], anemia/co [Complication], anemia/si [Side Effect], anorexia/si [Side Effect], article, bleeding/co [Complication], bleeding/si [Side Effect], cancer chemotherapy, cancer radiotherapy, cancer staging, cancer survival, clinical article, clinical trial, controlled clinical trial, controlled study, diarrhea/si [Side Effect], dose calculation, dose response, drug safety, edema/co [Complication], cisplatin/ae [Adverse Drug Reaction], cisplatin/cb [Drug Combination], cisplatin/do [Drug Dose], cisplatin/iv [Intravenous Drug Administration], paclitaxel/ae [Adverse Drug Reaction], paclitaxel/cb [Drug Combination], paclitaxel/do [Drug Dose], paclitaxel/dt [Drug Therapy], paclitaxel/iv [Intravenous Drug Administration], esophagitis/co [Complication], esophagitis/si [Side Effect], female, hiccup/si [Side Effect], human, human tissue, hyperglycemia/si [Side Effect], infection/si [Side Effect], insomnia/si [Side Effect], lung disease/si [Side Effect], lung non small cell cancer/dt [Drug Therapy], lung non small cell cancer/rt [Radiotherapy], lymphadenopathy, malaise/si [Side Effect], male, multimodality cancer therapy, muscle injury/co [Complication], nausea/co [Complication], nausea/si [Side Effect], neuropathy/si [Side Effect], neutropenia/co [Complication], neutropenia/si [Side Effect], phase 1 clinical trial, phase 2 clinical trial, pleura effusion, priority journal, radiation dose, radiation pneumonia/co [Complication], radiation response, thrombocytopenia/co [Complication], thrombocytopenia/si [Side Effect], tinnitus/si [Side Effect], treatment outcome, treatment planning, vomiting/co [Complication], vomiting/si [Side Effect], antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/cb [Drug Combination], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], carboplatin/ae [Adverse Drug Reaction], carboplatin/cb [Drug Combination], carboplatin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32772Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: cisplatin/dt [Drug Therapy], adult, aged, alopecia/co [Complication], alopecia/si [Side Effect], anemia/co [Complication], anemia/si [Side Effect], anorexia/si [Side Effect], article, bleeding/co [Complication], bleeding/si [Side Effect], cancer chemotherapy, cancer radiotherapy, cancer staging, cancer survival, clinical article, clinical trial, controlled clinical trial, controlled study, diarrhea/si [Side Effect], dose calculation, dose response, drug safety, edema/co [Complication], cisplatin/ae [Adverse Drug Reaction], cisplatin/cb [Drug Combination], cisplatin/do [Drug Dose], cisplatin/iv [Intravenous Drug Administration], paclitaxel/ae [Adverse Drug Reaction], paclitaxel/cb [Drug Combination], paclitaxel/do [Drug Dose], paclitaxel/dt [Drug Therapy], paclitaxel/iv [Intravenous Drug Administration], esophagitis/co [Complication], esophagitis/si [Side Effect], female, hiccup/si [Side Effect], human, human tissue, hyperglycemia/si [Side Effect], infection/si [Side Effect], insomnia/si [Side Effect], lung disease/si [Side Effect], lung non small cell cancer/dt [Drug Therapy], lung non small cell cancer/rt [Radiotherapy], lymphadenopathy, malaise/si [Side Effect], male, multimodality cancer therapy, muscle injury/co [Complication], nausea/co [Complication], nausea/si [Side Effect], neuropathy/si [Side Effect], neutropenia/co [Complication], neutropenia/si [Side Effect], phase 1 clinical trial, phase 2 clinical trial, pleura effusion, priority journal, radiation dose, radiation pneumonia/co [Complication], radiation response, thrombocytopenia/co [Complication], thrombocytopenia/si [Side Effect], tinnitus/si [Side Effect], treatment outcome, treatment planning, vomiting/co [Complication], vomiting/si [Side Effect], antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/cb [Drug Combination], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], carboplatin/ae [Adverse Drug Reaction], carboplatin/cb [Drug Combination], carboplatin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32772Test
LibKey Link